Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Berends

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Drugs & Aging|July 21, 2022
Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients-A BioCAPTURE Registry StudyE L M Ter Haar, S E Thomas, J M P A van den Reek, et al.
American Journal of Clinical Dermatology|May 27, 2024
Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis TreatmentSarah E Thomas, Marieke M B Seyger, Josje E Mangnus, et al.
Acta Dermato-Venereologica|June 19, 2025
Real-world Cost per Responder Among Different Classes of Biologics for the Treatment of PsoriasisLinda T H Godding, Marieke M B Seyger, Albert Duvetorp, et al.
The Journal of Dermatological Treatment|January 24, 2024
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registryTamara W van Hal, Juul M P A van den Reek, Mark H Wenink, et al.
Journal of Psoriasis and Psoriatic Arthritis|April 4, 2025
Lower Drug Survival, Less Satisfaction and More Adverse Events in Females Using Biologics for Psoriasis: Results of the Dutch BioCAPTURE RegistryLiana Barenbrug, Renate G van der Molen, Jake S F Maurits, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Drugs & Aging|July 21, 2022
Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients-A BioCAPTURE Registry StudyE L M Ter Haar, S E Thomas, J M P A van den Reek, et al.
American Journal of Clinical Dermatology|May 27, 2024
Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis TreatmentSarah E Thomas, Marieke M B Seyger, Josje E Mangnus, et al.
Acta Dermato-Venereologica|June 19, 2025
Real-world Cost per Responder Among Different Classes of Biologics for the Treatment of PsoriasisLinda T H Godding, Marieke M B Seyger, Albert Duvetorp, et al.
The Journal of Dermatological Treatment|January 24, 2024
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registryTamara W van Hal, Juul M P A van den Reek, Mark H Wenink, et al.
Journal of Psoriasis and Psoriatic Arthritis|April 4, 2025
Lower Drug Survival, Less Satisfaction and More Adverse Events in Females Using Biologics for Psoriasis: Results of the Dutch BioCAPTURE RegistryLiana Barenbrug, Renate G van der Molen, Jake S F Maurits, et al.
Pageof 6